Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zein Biotechnology is an Egyptian biotechnology company specializing in the development and manufacturing of advanced molecular diagnostic solutions. The company focuses on providing high-quality Real-Time PCR kits for the detection and quantification of various pathogens, including HCV, HBV, HIV, and SARS-CoV-2. Beyond infectious diseases, Zein Biotechnology offers diagnostic tools for oncology and genetic testing to support clinical laboratories and healthcare providers. Their mission is to enhance healthcare accessibility through innovative and affordable diagnostic technologies in the Middle East and Africa. The company operates a GMP-compliant manufacturing facility, ensuring that their products meet international quality standards for clinical use. By localizing production, Zein Biotechnology plays a critical role in the regional supply chain for essential diagnostic reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zein Biotechnology.